Ligand validation:4CQY

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4CQY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CQY_NAG_A_1323	75%	56%	0.101	0.934	0.47	1.19	-	2	0	0	100%	0.9333
4CQY_NAG_E_1323	63%	58%	0.136	0.931	0.5	1.09	-	2	0	0	100%	0.9333
4CQY_NAG_C_1323	49%	61%	0.173	0.922	0.41	1.04	-	1	0	0	100%	0.9333
4CQY_NAG_E_1321	37%	54%	0.184	0.883	0.52	1.23	-	2	0	0	100%	0.9333
4CQY_NAG_A_1325	35%	57%	0.203	0.894	0.44	1.18	-	1	0	0	100%	0.9333
4CQY_NAG_A_1324	22%	48%	0.228	0.846	0.6	1.39	-	3	0	1	100%	0.9333
4CQY_NAG_C_1321	22%	55%	0.235	0.85	0.45	1.27	-	2	0	0	100%	0.9333
4CQY_NAG_C_1322	12%	53%	0.253	0.783	0.44	1.37	-	2	0	0	100%	0.9333
4CQY_NAG_E_1322	11%	53%	0.283	0.806	0.57	1.25	-	3	1	1	100%	0.9333
4CQW_NAG_A_1011	80%	55%	0.117	0.966	0.45	1.25	-	1	0	0	100%	0.9333
4CQX_NAG_C_1322	79%	53%	0.093	0.94	0.51	1.29	-	2	0	0	100%	0.9333
4CQV_NAG_C_1011	59%	61%	0.156	0.94	0.49	0.97	-	2	0	0	100%	0.9333
5E2Z_NAG_C_1001	39%	79%	0.176	0.882	0.38	0.47	-	-	0	0	100%	0.9333
5E30_NAG_E_1001	15%	73%	0.272	0.831	0.52	0.5	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.